Your Family Will Thank You For Getting This Fentanyl Citrate Solubility UK

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This post is intended for instructional and professional info purposes just. Fentanyl citrate is a Class A controlled compound in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formula should just be conducted by licensed experts in regulated environments.

In the world of pharmacology and scientific medicine, fentanyl citrate stays one of the most potent synthetic opioids readily available. Due to its high effectiveness and rapid start of action, it is a foundation of pain management and anaesthesia in the UK's National Health Service (NHS) and personal healthcare sectors. However, the pharmacological effectiveness of any drug is inherently connected to its physicochemical properties-- particularly its solubility.

Understanding the solubility of fentanyl citrate is essential for pharmacists, researchers, and clinicians to make sure steady formulations, precise dosing, and effective drug delivery across different administration paths.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is extremely lipophilic (fat-soluble), it possesses restricted solubility in liquid environments. By responding the base with citric acid, moving into the salt form (fentanyl citrate), the solubility in water is significantly improved. This makes it appropriate for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is made according to the requirements set by the British Pharmacopoeia (BP). Buy Fentanyl In The UK looks like a white, crystalline powder or as granules that are odorless.

Key Physicochemical Properties

Home

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Around 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate differs drastically depending


on the solvent used and the ambient temperature level. In

a pharmaceutical setting, water is the primary solvent of interest for injectables, but natural solvents are typically utilized throughout the manufacturing of transdermal patches or nasal sprays. Aqueous Solubility In the UK medical context, fentanyl citrate is most frequently come across as a 50 mcg/mL solution for injection. At space temperature(around 20 ° C to 25 ° C), fentanyl

citrate is thought about"sparingly soluble"in water. Scientific literature usually suggests a solubility limit of roughly 25 mg/mL in water at 25 ° C, which is more than adequate for basic clinical concentrations. Organic Solvent Solubility Fentanyl citrate exhibits varied solubility in natural solvents, which is important for creating non-aqueous drug delivery systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Sparingly Soluble ~ 25 mg/mL Methanol Easily Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol Somewhat Soluble

<10 mg/mL Factors Influencing Solubility and Stability The solubility of fentanyl citrate is not a static value; it

is affected by numerous ecological and chemical factors that need to be managed during intensifying and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate remains highly soluble in acidic to neutral options. Many UK-licensed fentanyl injections are buffered to a pH variety of

4.0 to 7.5. Alkaline Environments: If the pH of a service increases considerably above 7.5, there is a danger that the fentanyl


will transition back into its base type. Due to the fact that the base

form is significantly less soluble in water, this can cause"crashing out"or rainfall, which is very unsafe in an IV setting. 2. Temperature Effects Like many crystalline solids, the solubility of fentanyl citrate increases with temperature level. While this is practical during the commercial dissolution process, it presents a risk throughout storage . If a saturated solution is prepared at a high temperature and then cooled (such as during transportation in cold UK winter seasons), the solute might take shape. 3. Presence of Other Ions(Common **Ion Effect )The presence of other citrate salts in the service can decrease the solubility of fentanyl citrate due to the typical ion result. This is a vital factor to consider when blending fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The option of buffer(e.g., sodium citrate or phosphate buffers)is

critical in maintaining a steady environment where the drug stays in its ionized, soluble form. Developing for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medicinal products need to stick to the British Pharmacopoeia(BP). The BP supplies specific monographs for Fentanyl Citrate, guaranteeing purity, effectiveness, and solubility requirements are satisfied. Key Compounding and Formulation Rules: Clarity of Solution: The BP requires that parenteral services be clear and devoid of noticeable particles. This is accomplished by guaranteeing the concentration stays well below the saturation point. Sterility: Given the aqueous nature of the service, formulations need to be

### sanitized, typically

via autoclaving or filtering, which can affect the stability if the solubility limitations are tight. Excipients: Common additives in UK fentanyl formulations consist of Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH modification). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the health care specialist? Preventing Precipitation: Knowing that fentanyl is incompatible with extremely alkaline

**solutions(like thiopentone or some bicarbonate options

*   **)avoids the formation of precipitates that might trigger embolic occasions. Optimizing Drug Delivery: In the advancement of sublingual or buccal tablets (e.g., Abstral or Effentora utilized in the UK), the drug must dissolve*   **rapidly in the little volume of saliva readily available. Transdermal Flux: While spots rely on the lipophilicity of the fentanyl base, the manufacture of these patches frequently includes dissolving the citrate salt in an unstable solvent*   **before it is impregnated into the adhesive matrix. Storage and Handling Recommendations To keep the solubility and effectiveness of fentanyl citrate items, the following standards are generally

            * * *

            followed in British clinical settings: Temperature
            --------------------------------------------------

            Control: Store at regulated room temperature level (15 ° C to 25 ° C). Avoid freezing, as this can cause irreparable precipitation in**certain formulas. Light** Protection: Fentanyl citrate is somewhat light-sensitive. Aqueous services need to be kept in amber glass or opaque packaging. Managing Potency: Because of its high solubility and effectiveness, unintentional skin contact*   **with focused services** can cause systemic absorption. Expert PPE is compulsory. Frequently Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, significantly.
            *   **The citrate salt is created specifically to increase liquid solubility, making it suitable for injections. The base form is extremely lipophilic and is normally used in the internal layers of transdermal spots. Does the UK BP(British Pharmacopoeia)vary

                from the USP concerning solubility? The general

                solubility profiles are similar as they explain the exact same chemical entity. Nevertheless, the precise screening approaches and the prioritized solvents for purity screening may differ

                *   **a little between the BP** and the United States Pharmacopeia (USP). Can I blend fentanyl citrate with saline? Yes. Fentanyl citrate is compatible with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are standard diluents used in UK medical facilities. What occurs if a fentanyl solution ends up being cloudy? If a solution of fentanyl citrate appears cloudy or includes** crystals, it should be discarded. This indicates that the drug has actually sped up out of the solution, either due to pH modifications, temperature shifts, or contamination.

                * * *

                Why is citric acid utilized particularly?
                -----------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade organic acid. [Fentanyl For Sale UK](https://hedgedoc.eclair.ec-lyon.fr/s/xGROmprko) forms a stable salt with fentanyl that provides a balance of high water solubility and compatible pH for human tissue. Fentanyl citrate is an important medicinal tool in the UK, however its safety and effectiveness are predicated on

                ### its chemical stability. Solubility is maybe the most important element in this regard

                . By keeping an optimum pH, selecting the right solvents, and adhering to British Pharmacopoeia requirements, the pharmaceutical market ensures that this potent analgesic stays a trusted choice for client care.

                ### For clinicians, the takeaway is easy: always confirm compatibility before blending and guarantee storage conditions are strictly met to avoid the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 26 May 2026 18:48 UTC

Views: 1